Antibody technology as a cancer imaging agent
23 October, 2015Minomic International will next year launch a human study of its monoclonal antibody technology as an imaging agent to detect prostate, pancreatic and bladder cancers.
Could an arthritis drug slow diabetes development in children?
19 October, 2015JDRF has announced a new clinical trial to slow the development of newly diagnosed type 1 diabetes in children. The trial will test a new application of an existing drug currently approved for use in children with juvenile arthritis.
Breast cancer vaccine completes preclinical proof-of-concept study
16 October, 2015Breast cancer vaccine candidate OQR200, developed by OncoQR, has successfully completed a proof-of-concept study in non-human primates (NHPs).
$1.4 million to advance Australian biomedical research
16 October, 2015The 2015 recipients of the Ramaciotti Awards for Biomedical Research, distributed by the Clive and Vera Ramaciotti Foundations, have been revealed.
Prescient MD resigns
15 October, 2015Dr Robert Crombie, the managing director of oncology company Prescient Therapeutics, has resigned in order to focus on other business opportunities.
ASCVD drug trial terminated due to insufficient efficacy
15 October, 2015Eli Lilly and Company (Lilly) will terminate its phase 3 trial of the investigational medicine evacetrapib due to insufficient efficacy.
Myelin researcher scores AbbVie Student Poster Award
13 October, 2015The 2015 AbbVie Student Poster Awards recognised the important research being carried out by Australian graduate students in areas such as pharmaceutical sciences, disease research, biology and nutritional science.
Cancer and blood researchers elected as AAHMS fellows
09 October, 2015Three researchers from the Walter and Eliza Hall Institute have been elected as fellows of the Australian Academy of Health and Medical Sciences in recognition of their contributions to Australian medical research.
Australia partners with the US on brain research
01 October, 2015The NHMRC and the US National Institutes of Health have opened a joint funding round as part of the BRAIN Initiative — part of a presidential focus aimed at revolutionising our understanding of the human brain.
Fusion cancer treatment to be developed by Clarity
11 September, 2015Clarity Pharmaceuticals has signed an exclusive licensing agreement with CRO Fusion Antibodies to further develop a Cathepsin S-specific antibody for the treatment of cancer.
Funding a cure for type 1 diabetes
11 September, 2015Researchers based at the Westmead Millennium Institute for Medical Research and Westmead Hospital have been awarded $3.3 million to extend their research into a clinical cure for type 1 diabetes.
Call for breast cancer assay to be reimbursed
08 September, 2015Medical experts have called for the Oncotype DX Breast Cancer Assay, developed by Genomic Health, to be considered for reimbursement in Australia.
11 NHMRC grants for international research collaborations
04 September, 2015The NHMRC has announced 11 grants to support international collaborative research on health issues such as heart attacks, dementia, stroke and leukaemia.
Patents and positive clinical data from Prescient
01 September, 2015Prescient Therapeutics has announced the acquisition of two new US patents to protect its cancer drug PTX-200, which last week provided the company with encouraging early clinical data in an ongoing study.
Leslie Chong appointed Imugene COO
28 August, 2015Imugene has appointed Leslie Chong as its new chief operating officer as of mid-September — a move which saw the company's share price rise by 25% on Thursday.
